DiscGenics to Study Cell Therapy for Degenerative Disease
The company gained FDA approval to proceed with Phase III clinical evaluation of allogeneic, injectable disc progenitor cell therapy for...
The company gained FDA approval to proceed with Phase III clinical evaluation of allogeneic, injectable disc progenitor cell therapy for...
VisiCORE is a bone graft harvesting system for foot and ankle fusion designed with a clear collection tube with proprietary...
Cytonics initiated enrollment to study a recombinant variant of the alpha-2-macroglobulin blood serum protein to treat cartilage degradation....
The patented technology, which will be commercialized as Amplify granules, will become a major component of Ventris' synthetic bone graft...
The results showed that TrelCor exhibited a robust bioactive response and was capable of stimulating bone forming cells....
This designation addresses Infuse in a TLIF approach in the treatment of degenerative disease of the lumbosacral spine....
Catalyst nanosynthetic bone graft stimulates the formation of healthy bone tissue in spinal fusion surgeries....
Upon hydration, the graft transforms into a pliable form that can be tailored to meet precise needs of diverse surgical...
Expanded indications for Agilon Moldable and Morpheus Moldable address use in the intervertebral disc space as an autograft extender....
Lipogems completed enrollment in the ARISE I FDA IDE study examining MicroFat vs. corticosteriod injection for the treatment of knee...
As a guest member you get access to more articles and videos every month.
We’ll send a recovery link to your email.
Return to Homepage